Drew Dinsick and Vaughn Dalzell examine the Final Four market, giving bettors insight on who they should stay away from and who is giving good value right now.
The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...
Purdue junior guard Braden Smith has been named one of 10 semifinalist for the Bob Cousy Award, presented to the top point ...
Connecticut has joined a new $7.4 billion settlement agreement with OxyContin maker Purdue Pharma and the Sackler family members who own the company.
The billionaire family that owns Purdue Pharma, maker of the pain medication ... according to the offices of the New York and Connecticut attorneys general; money not used after five years would ...
Sackler family, Purdue Pharma to pay $7.4 billion to settle opioid case with CT, NY and other states
Connecticut, New York and 13 other states have announced a tentative $7.4 billion settlement with the Sackler family and ...
Purdue Pharma, owners could pay $7.4 billion in new settlement over toll of OxyContin Connecticut will get more than $60 million to compensate victims and find a way to stop opioid addiction.
Bankrupt Purdue Pharma LP and members of the billionaire Sackler family agreed to pay $7.4 billion to a group of US states, ...
pursued by states who never backed down," Connecticut Attorney General William Tong said Thursday. "Today, we are forcing Purdue Pharma and the Sackler family to pay $7.4 billion for their role in ...
Purdue Pharma owners could pay $7.4 billion in new settlement to lawsuits over the toll of OxyContin
Members of the family who own Connecticut-based OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller ...
Members of the family who own OxyContin maker Purdue Pharma and the company itself agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
12don MSN
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results